Stay updated on Omalizumab in Multi-Allergen OIT Clinical Trial
Sign up to get notified when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.

Latest updates to the Omalizumab in Multi-Allergen OIT Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4. This indicates a minor update to the page build/metadata without changing study details.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe ClinicalTrials.gov page’s footer revision/version number was updated from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check67 days agoChange DetectedWebsite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page now shows Revision: v3.4.3 and the previous Revision: v3.4.2 label has been removed.SummaryDifference0.0%

- Check102 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check110 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

Stay in the know with updates to Omalizumab in Multi-Allergen OIT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.